Back to School: How biopharma can reboot drug development. Access exclusive analysis here

LipoRed: mbt began an open-label German Phase Ib/II trial of LipoRed in an undisclosed number of patients

mbt Munich Biotechnology AG, Martinsried, Germany

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE